 NuVasive Inc NASDAQ: NUVA reported Q3 net sales of 270.8 million, an 8.3 decrease on a reported and constant currency basis, missing the consensus of 291.79 million. The third quarter presented unexpected challenges for elective surgical procedures due to the negative impact from the resurgence of COVID-19 and healthcare staffing shortages, said J. 